Search

everythinglearnresearchcommunity

for

Search:↓

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Angiogenin helps hair grow by stimulating cell growth and blood vessel formation.

Laser hair removal can cause a severe itchy rash in some allergic individuals, treatable with steroids.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Dermoscopy is useful for identifying and tracking different types of hair loss without scarring.

A dermatoscope is important for evaluating hair transplants and managing patient expectations.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Treatments for melanin disorders exist, but more effective options needed.

Minoxidil promotes hair growth but stops working when discontinued.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Melanocyte development from neural crest cells is complex and influenced by many factors, and better understanding could help treat skin disorders.

Using dermoscopy to guide scalp biopsies is an effective way to diagnose cicatricial alopecia.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

The HoVert technique is a simple, cost-effective new method that improves alopecia diagnosis by allowing detailed analysis from a single biopsy.

Nonablative radiofrequency treatments, especially microneedle and fractional types, can improve acne scars by 25%–75% after 3-4 sessions, with full results in 3 months and some side effects.

Psoriasis can cause temporary or permanent hair loss.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The document concludes that stopping shaving or removing affected hair can alleviate Pseudofolliculitis barbae (PFB).

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.